Abstract
Abstract
Congenital cytomegalovirus (CMV) infection is a common cause of sensorineural hearing loss and neurodevelopmental impairment in newborns. However, congenital CMV infection cannot be diagnosed using samples collected more than 3 weeks after birth because testing after this time cannot distinguish between congenital infection and postnatal infection. Herein, we developed a robust loop-mediated isothermal amplification (LAMP) assay for the large-scale screening of newborns for congenital CMV infection. In contrast to conventional quantitative polymerase chain reaction (qPCR), which detects CMV within a dynamic range of 1.0 × 106 to 1.0 × 102 copies/μL, our quantitative LAMP assay (qLAMP) detects CMV within a dynamic range of 1.1 × 108 to 1.1 × 103 copies/μL. Moreover, the turnaround time for obtaining results following DNA extraction is 90 min in qPCR but only 15 min in qLamp. The colorimetric LAMP assay can also detect CMV down to 1.1 × 103 copies/μL within 30 min, irrespective of the type of heat source. Our LAMP assay can be utilized in central laboratories as an alternative to conventional qPCR for quantitative CMV detection, or for point-of-care testing in low-resource environments, such as developing countries, via colorimetric naked-eye detection.
Key points
• LAMP assay enables large-scale screening of newborns for congenital CMV infection.
• LAMP allows colorimetric or quantitative detection of congenital CMV infection.
• LAMP assay can be used as a point-of-care testing tool in low-resource environments.
Funder
Korea Health Industry Development Institute
National Research Foundation of Korea
Future Medicine 2030 Project of the Samsung Medical Center
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Reference55 articles.
1. Akpan US, Pillarisetty LS (2022) Congenital cytomegalovirus infection, in StatPearls. Treasure Island (FL): StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK541003/. Accessed 15 Sept 2023
2. Bae IK, Jeong S, Kim YJ, Kim MJ, Jeong SH (2013) Comparison cytomegalovirus qualitative assay using realtime PCR and conventional PCR. Ann Clin Microbiol 16(1):19–24. https://doi.org/10.5145/ACM.2013.16.1.19
3. Boppana SB, Ross SA, Fowler KB (2013) Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 57(Suppl 4):S178–S181. https://doi.org/10.1093/cid/cit629
4. Bristow BN, O’Keefe KA, Shafir SC, Sorvillo FJ (2011) Congenital cytomegalovirus mortality in the United States, 1990–2006. PLOS Negl Trop Dis 5(4):e1140. https://doi.org/10.1371/journal.pntd.0001140
5. Cannon MJ, Griffiths PD, Aston V, Rawlinson WD (2014) Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Rev Med Virol 24(5):291–307. https://doi.org/10.1002/rmv.1790